Floatz logo

IRON SUCCINATE (FE(O4C4H4))

Hematopoietic Stem Cell Transplantation

Peking UniversitySmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hematopoietic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3BB
CYCLOSPORIN A
The First Affiliated Hospital of Soochow University
Phase 4BB
METHOTREXATE
The First Affiliated Hospital of Soochow University
Phase 3BB
Folic Acid
Peking University
Phase 4BB
Iron
Peking University
Phase 4BB

View all 15 →

Same molecule, other indications

IRON SUCCINATE (FE(O4C4H4)) is also rated in:

AnemiaDormant
BB
Indicative ·
65 / 100
View asset →
Phenylketonuria (PKU)Dormant
B
Indicative ·
57 / 100
View asset →
LymphomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →